-The Indian Express The Supreme Court on Thursday gave one month’s time to the Centre to come up with the final version of the drug pricing policy. Maintaining that the Centre must follow a pricing formula that will prevent the prices of the drugs from shooting up, the SC agreed to wait till mid-November for the Cabinet to come up with its final version of the new pricing policy. “Drugs prescribed by doctors......
More »SEARCH RESULT
A short-sighted cap-Chandra M Gulhati
-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...
More »Medicines should be within reach of common man: SC
-IANS Protecting the interest of the common man, the Supreme Court Wednesday told the government not to disturb the existing retail price mechanism of drugs under the price control order while finalising the list of essential medicines. The judges observed that the prices of the drugs were so high that it left the patient with the option of either to die or buy medicines by selling one's land or ornaments. "The common man...
More »WHO pans India for morphine curbs -Kounteya Sinha
-The Times of India Strong control over morphine — a highly effective painkiller that has left millions of Indians in needless pain — has left India red-faced on the global stage. Calling use of opioid analgesics like morphine "sub-optimal" in India, the World Health Organization (WHO) on Wednesday asked India to immediately reassess regulatory requirements on the dispensing of essential medicines like morphine to ensure their wider availability and accessibility besides sensitizing...
More »Drug makers may dodge price control-Sushmi Dey
-The Business Standard The proposed pharma pricing policy may give room to drug makers to escape price control. While the policy is primarily aimed at making essential medicines affordable, many feel the spirit is missing in the recommendations put forward by a group of ministers a few days ago. For instance, the ministerial panel has proposed to regulate prices of only 348 essential medicines and keep combination products out of control —...
More »